R. A. Van-den-berg, M. Coccia, W. R. Ballou, K. E. Kester, C. F. Ockenhouse et al., Predicting RTS,S vaccine-mediated protection from transcriptomes in a malaria-challenge clinical trial. Front Immunol, vol.8, p.557, 2017.

D. Kazmin, H. I. Nakaya, E. K. Lee, M. J. Johnson, R. Van-der-most et al., Systems analysis of protective immune responses to RTS,S malaria vaccination in humans, Proc Natl Acad Sci, vol.114, pp.2425-2430, 2017.

W. Burny, A. Callegaro, V. Bechtold, F. Clement, S. Delhaye et al., Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans, Front Immunol, vol.8, p.943, 2017.

A. M. Didierlaurent, C. Collignon, P. Bourguignon, S. Wouters, K. Fierens et al., Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells, J. Immunol, vol.193, pp.1920-1930, 2014.

A. M. Didierlaurent, S. Morel, L. Lockman, S. L. Giannini, M. Bisteau et al., AS04, an aluminum salt-and TLR4 agonistbased adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity, J. Immunol, vol.183, pp.6186-6197, 2009.

S. Morel, A. Didierlaurent, P. Bourguignon, S. Delhaye, B. Baras et al., Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity, vol.29, pp.2461-2473, 2011.

A. Seubert, E. Monaci, M. Pizza, D. T. O'hagan, and A. Wack, The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells, J. Immunol, vol.180, pp.5402-5412, 2008.

, The Authors, European Journal of Immunology, 2019.

M. Kwissa, H. I. Nakaya, H. Oluoch, and B. Pulendran, Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates, Blood, vol.119, pp.2044-2055, 2012.

F. Liang, G. Lindgren, K. J. Sandgren, E. A. Thompson, J. R. Francica et al., Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake, Sci. Transl. Med, vol.9, 2017.

P. Duewell, U. Kisser, K. Heckelsmiller, S. Hoves, P. Stoitzner et al., ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells, J. Immunol, vol.187, pp.55-63, 2011.

C. Reis-e-sousa, Sensing infection and tissue damage, EMBO Mol. Med, vol.9, pp.285-288, 2017.

A. L. Desbien, Analysis of the innate response to adjuvants: characterization of the draining lymph node by fluorescence-activated cell sorting, Methods Mol. Biol, vol.1494, pp.305-312, 2017.

M. Coccia, C. Collignon, C. Herve, A. Chalon, I. Welsby et al., Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNgamma response promoting vaccine immunogenicity, NPJ Vaccines, vol.2, p.25, 2017.

I. Welsby, S. Detienne, F. N'kuli, S. Thomas, S. Wouters et al., Lysosome-dependent activation of human dendritic cells by the vaccine adjuvant QS-21, Front. Immunol, vol.7, p.663, 2016.

J. H. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi et al., Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin, Infect. Immun, vol.74, pp.6829-6838, 2006.

A. M. Didierlaurent, B. Laupeze, A. Di-pasquale, N. Hergli, C. Collignon et al., Adjuvant system AS01: helping to overcome the challenges of modern vaccines, Expert Rev. Vaccines, vol.16, pp.55-63, 2017.

S. Detienne, I. Welsby, C. Collignon, S. Wouters, M. Coccia et al., Central role of CD169 + lymph node resident macrophages in the adjuvanticity of the QS-21 component of AS01, Sci. Rep, vol.6, p.39475, 2016.

W. Burny, A. Marchant, C. Herve, A. Callegaro, M. Caubet et al., Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans, vol.37, pp.2004-2015, 2019.

P. Shinde, W. Liu, A. Menoret, A. D. Luster, and A. T. Vella, Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production, J. Leukoc Biol. 2017, vol.102, pp.57-69

R. N. Coler, S. Bertholet, M. Moutaftsi, J. A. Guderian, H. P. Windish et al., Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant, PLoS One, vol.6, p.16333, 2011.

L. Luan, N. K. Patil, Y. Guo, A. Hernandez, J. K. Bohannon et al., Comparative transcriptome profiles of human blood in response to the toll-like receptor 4 ligands lipopolysaccharide and monophosphoryl lipid A, p.40050

R. Sporri and C. Reis-e-sousa, Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function, Nat. Immunol, vol.6, pp.163-170, 2005.

K. Ersland, M. Wuthrich, and B. S. Klein, Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi, Cell Host Microbe, vol.7, pp.474-487, 2010.

M. Samstein, H. A. Schreiber, I. M. Leiner, B. Susac, M. S. Glickman et al., Essential yet limited role for CCR2(+) inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming, p.1086, 2013.

G. Coma, R. Pena, J. Blanco, A. Rosell, F. E. Borras et al., Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10, Clin. Exp. Immunol, vol.145, pp.535-544, 2006.

E. Padovan, G. C. Spagnoli, M. Ferrantini, and M. Heberer, IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells, J. Leukoc Biol, vol.71, pp.669-676, 2002.

E. Zigmond, C. Varol, J. Farache, E. Elmaliah, A. T. Satpathy et al., Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells, Immunity, vol.37, pp.1076-1090, 2012.

S. P. Kasturi, I. Skountzou, R. A. Albrecht, D. Koutsonanos, T. Hua et al., Programming the magnitude and persistence of antibody responses with innate immunity, Nature, vol.470, pp.543-547, 2011.

N. Dendouga, M. Fochesato, L. Lockman, S. Mossman, and S. L. Giannini, Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice, vol.30, pp.3126-3135, 2012.

H. Liang, S. E. Hussey, A. Sanchez-avila, P. Tantiwong, and N. Musi, Effect of lipopolysaccharide on inflammation and insulin action in human muscle, PLoS One, vol.8, p.63983, 2013.

R. J. Stark, H. Choi, S. R. Koch, B. A. Fensterheim, F. S. Lamb et al., Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A, Clin. Sci, vol.130, pp.451-461, 2016.

H. Hammad, M. Chieppa, F. Perros, M. A. Willart, R. N. Germain et al., House dust mite allergen induces asthma via Tolllike receptor 4 triggering of airway structural cells, Nat. Med, vol.15, pp.410-416, 2009.

N. Noulin, V. F. Quesniaux, S. Schnyder-candrian, B. Schnyder, I. Maillet et al., Both hemopoietic and resident cells are required for MyD88-dependent pulmonary inflammatory response to inhaled endotoxin, J. Immunol, vol.175, pp.6861-6869, 2005.

L. Van-maele, D. Fougeron, L. Janot, A. Didierlaurent, D. Cayet et al., Airway structural cells regulate TLR5-mediated mucosal adjuvant activity, Mucosal Immunol, vol.7, pp.489-500, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00925663

A. Cossarizza, H. D. Chang, A. Radbruch, M. Akdis, I. Andra et al., Guidelines for the use of flow cytometry and cell sorting in immunological studies, Eur. J. Immunol, vol.47, pp.1584-1797, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01619848

, Belgium e-mail: arnaud.x.didierlaurent@gsk.com The peer review history for this article is, Abbreviations: AS: Adjuvant System · DC: dendritic cell · dLN: draining lymph node · HBs: Hepatitis B surface antigen · ILLN: draining iliac lymph node · MPL: 3-O-desacyl-4'-monophosphoryl lipid A Full correspondence: Dr. Arnaud Didierlaurent, GSK